Published in Cell on August 19, 2011
Interferon-ε protects the female reproductive tract from viral and bacterial infection. Science (2013) 1.73
Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes. Biochemistry (2012) 1.57
Type I interferons link viral infection to enhanced epithelial turnover and repair. Cell Host Microbe (2014) 1.53
Growth Factor Identity Is Encoded by Discrete Coiled-Coil Rotamers in the EGFR Juxtamembrane Region. Chem Biol (2015) 1.43
Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1. Nat Immunol (2013) 1.41
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev (2012) 1.38
Evolutionary genetic dissection of human interferons. J Exp Med (2011) 1.32
Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol (2011) 1.31
Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol (2015) 1.22
Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy. J Interferon Cytokine Res (2013) 1.07
Interferons and their stimulated genes in the tumor microenvironment. Semin Oncol (2014) 1.07
Structure of the activating IL-1 receptor signaling complex. Nat Struct Mol Biol (2012) 1.06
Multifaceted activities of type I interferon are revealed by a receptor antagonist. Sci Signal (2014) 1.04
Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-α receptor 1 antibody. MAbs (2015) 1.04
Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol (2011) 1.04
Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands. Cell (2015) 1.02
Parsing the Interferon Transcriptional Network and Its Disease Associations. Cell (2016) 1.01
Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection. Cell Host Microbe (2015) 1.01
Subversion of cytokine networks by virally encoded decoy receptors. Immunol Rev (2012) 0.98
Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity. Front Immunol (2014) 0.91
Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy. J Neuroimmunol (2012) 0.90
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections. J Interferon Cytokine Res (2015) 0.90
Interferon gamma receptor: the beginning of the journey. Front Immunol (2013) 0.89
Understanding cytokine and growth factor receptor activation mechanisms. Crit Rev Biochem Mol Biol (2012) 0.88
Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling. J Cell Biol (2015) 0.88
Insights into cytokine-receptor interactions from cytokine engineering. Annu Rev Immunol (2014) 0.87
Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats. Proc Natl Acad Sci U S A (2016) 0.87
Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Hum Mol Genet (2012) 0.87
Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury. EMBO Mol Med (2014) 0.87
Bridging the species divide: transgenic mice humanized for type-I interferon response. PLoS One (2014) 0.87
IFN signaling: how a non-canonical model led to the development of IFN mimetics. Front Immunol (2013) 0.87
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases. Gene (2015) 0.87
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types. Front Immunol (2014) 0.85
Live cell micropatterning reveals the dynamics of signaling complexes at the plasma membrane. J Cell Biol (2014) 0.84
Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands. Mol Cell Biol (2012) 0.84
Multifarious determinants of cytokine receptor signaling specificity. Adv Immunol (2014) 0.83
Reactive oxygen species and IRF1 stimulate IFNα production by proximal tubules during ischemic AKI. Am J Physiol Renal Physiol (2013) 0.82
The role of a non-canonical JAK-STAT pathway in IFN therapy of poxvirus infection and multiple sclerosis: An example of Occam's Broom? JAKSTAT (2013) 0.81
Distinct evolution process among type I interferon in mammals. Protein Cell (2013) 0.81
Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections. J Interferon Cytokine Res (2014) 0.81
Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections. Immunol Res (2013) 0.81
Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes. Cell (2016) 0.81
Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo. J Virol (2016) 0.81
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency. Sci Signal (2015) 0.80
IL-2 and IL-15 signaling complexes: different but the same. Nat Immunol (2012) 0.80
A single N-acetylgalactosamine residue at threonine 106 modifies the dynamics and structure of interferon α2a around the glycosylation site. J Biol Chem (2012) 0.80
The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Curr Top Microbiol Immunol (2014) 0.80
Molecular evolution of the porcine type I interferon family: subtype-specific expression and antiviral activity. PLoS One (2014) 0.79
Fine Tuning of a Type 1 Interferon Antagonist. PLoS One (2015) 0.79
Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation. Cell (2017) 0.78
Type I interferons in viral control and immune regulation. Curr Opin Virol (2016) 0.78
ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system. Oncotarget (2016) 0.78
Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord. PLoS One (2016) 0.78
Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain. J Biol Chem (2015) 0.77
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms. J Interferon Cytokine Res (2014) 0.77
Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers. Protein Sci (2013) 0.77
Differential activity of type I interferon subtypes for dendritic cell differentiation. PLoS One (2013) 0.77
Molecular Mechanisms Governing Differential Type I Interferons Signaling. J Biol Chem (2017) 0.76
Type I interferon mimetics bypass vaccinia virus decoy receptor virulence factor for protection of mice against lethal infection. Clin Vaccine Immunol (2014) 0.76
A potent in vivo anti-tumor efficacy of novel recombinant type I interferon. Clin Cancer Res (2016) 0.76
Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells. Clin Exp Immunol (2012) 0.76
Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures. Nat Rev Immunol (2016) 0.76
Spatiotemporal control of interferon-induced JAK/STAT signalling and gene transcription by the retromer complex. Nat Commun (2016) 0.76
Immunoinflammatory diseases of the central nervous system - the tale of two cytokines. Br J Pharmacol (2015) 0.76
High-density nucleosome occupancy map of human chromosome 9p21-22 reveals chromatin organization of the type I interferon gene cluster. J Interferon Cytokine Res (2014) 0.76
Binding of interferon reduces the force of unfolding for interferon receptor 1. PLoS One (2017) 0.75
Endotoxin tolerance in monocytes can be mitigated by α2-interferon. J Leukoc Biol (2015) 0.75
Receptor dimer stabilization by hierarchical plasma membrane microcompartments regulates cytokine signaling. Sci Adv (2016) 0.75
Evolution of Interferons and Interferon Receptors. Front Immunol (2017) 0.75
A hot-spot on interferon alpha/beta receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling. J Biol Chem (2017) 0.75
Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab. J Biol Chem (2015) 0.75
Structural basis of the broadly neutralizing anti-interferon-α antibody rontalizumab. Protein Sci (2015) 0.75
Crystal structure of human interferon-γ receptor 2 reveals the structural basis for receptor specificity. Acta Crystallogr D Struct Biol (2016) 0.75
Cytokines: Structuring the type I IFN response. Nat Rev Immunol (2011) 0.75
Cytokine Activation by Antibody Fragments Targeted to Cytokine-Receptor Signaling Complexes. J Biol Chem (2015) 0.75
Type I Interferons as Regulators of Lung Inflammation. Front Immunol (2017) 0.75
Dynamic Modulation of Binding Affinity as a Mechanism for Regulating Interferon Signaling. J Mol Biol (2017) 0.75
IFNA2: The prototypic human alpha interferon. Gene (2015) 0.75
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity. Immunity (2017) 0.75
Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment. Front Endocrinol (Lausanne) (2017) 0.75
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Automated structure solution with autoSHARP. Methods Mol Biol (2007) 14.67
Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci (1957) 13.46
Type 1 interferons and the virus-host relationship: a lesson in détente . Science (2006) 6.33
Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov (2007) 6.33
Interferons, interferon-like cytokines, and their receptors. Immunol Rev (2004) 6.21
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods (2006) 5.25
Complex modulation of cell type-specific signaling in response to type I interferons. Immunity (2006) 4.48
Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature (1995) 2.74
Insights into MHC class I peptide loading from the structure of the tapasin-ERp57 thiol oxidoreductase heterodimer. Immunity (2009) 2.46
Structural biology of shared cytokine receptors. Annu Rev Immunol (2009) 2.27
The receptor of the type I interferon family. Curr Top Microbiol Immunol (2007) 1.94
The function of type I interferons in antimicrobial immunity. Curr Opin Immunol (2000) 1.91
Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Mol Cell Biol (2006) 1.82
Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol (2008) 1.79
Differential receptor subunit affinities of type I interferons govern differential signal activation. J Mol Biol (2006) 1.67
Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity (2001) 1.64
BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies. Protein Expr Purif (2008) 1.53
The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities. J Biol Chem (2008) 1.33
New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J Biol Chem (2000) 1.29
Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure (1996) 1.26
Stochastic receptor expression determines cell fate upon interferon treatment. Mol Cell Biol (2011) 1.26
Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression. Proc Natl Acad Sci U S A (2005) 1.25
Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site. J Mol Biol (2005) 1.25
Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking. Proc Natl Acad Sci U S A (2001) 1.23
Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure (2008) 1.23
Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett (2008) 1.22
Receptor density is key to the alpha2/beta interferon differential activities. Mol Cell Biol (2009) 1.22
An interferon alpha2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities. J Biol Chem (2007) 1.21
Identification of a class of HCV inhibitors directed against the nonstructural protein NS4B. Sci Transl Med (2010) 1.20
Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem J (2007) 1.14
Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1. J Mol Biol (2005) 1.12
Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1. J Mol Biol (2010) 1.09
Ligand binding induces a conformational change in ifnar1 that is propagated to its membrane-proximal domain. J Mol Biol (2008) 1.02
Structural analysis of cytokines comprising the IL-10 family. Cytokine Growth Factor Rev (2010) 0.99
The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling. J Mol Biol (2007) 0.99
The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding. Structure (2003) 0.98
Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex. Protein Sci (2006) 0.97
Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. Biochemistry (2004) 0.97
Structural analysis of IL-10 and Type I interferon family members and their complexes with receptor. Adv Protein Chem (2004) 0.95
Hydrophobic cluster analysis reveals duplication in the external structure of human alpha-interferon receptor and homology with gamma-interferon receptor external domain. FEBS Lett (1990) 0.87
Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY. Biochemistry (2010) 0.85
Antitumor effects of interferon-omega: in vivo therapy of human tumor xenografts in nude mice. Cancer Res (1999) 0.79
Causal protein-signaling networks derived from multiparameter single-cell data. Science (2005) 34.28
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science (2011) 15.45
STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell (2009) 6.92
Computational solutions to large-scale data management and analysis. Nat Rev Genet (2010) 6.58
Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell (2004) 6.24
Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol (2011) 5.46
Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity (2012) 5.26
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods (2006) 5.25
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol (2013) 4.88
Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A (2003) 4.45
Structural basis of Wnt recognition by Frizzled. Science (2012) 4.31
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell (2008) 4.06
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell (2008) 3.72
Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol (2012) 3.65
Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science (2013) 3.59
Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell (2009) 3.46
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood (2010) 3.41
Helical structures of ESCRT-III are disassembled by VPS4. Science (2008) 3.38
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies. Science (2013) 3.25
Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat Rev Cancer (2006) 3.24
How a single T cell receptor recognizes both self and foreign MHC. Cell (2007) 3.20
ProMate: a structure based prediction program to identify the location of protein-protein binding sites. J Mol Biol (2004) 3.18
A deep profiler's guide to cytometry. Trends Immunol (2012) 3.14
Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol (2003) 3.03
Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science (2003) 2.87
Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat Immunol (2007) 2.78
Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin Immunol (2004) 2.69
Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science (2005) 2.64
Normalization of mass cytometry data with bead standards. Cytometry A (2013) 2.63
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog (2010) 2.62
Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol Cell (2003) 2.61
Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nat Immunol (2003) 2.58
Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron (2007) 2.54
High-content single-cell drug screening with phosphospecific flow cytometry. Nat Chem Biol (2007) 2.54
Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis. Nat Biotechnol (2008) 2.52
Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature (2013) 2.49
Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature (2002) 2.45
Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol (2002) 2.43
Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom (2010) 2.43
Chemical combination effects predict connectivity in biological systems. Mol Syst Biol (2007) 2.42
An extracellular interactome of immunoglobulin and LRR proteins reveals receptor-ligand networks. Cell (2013) 2.36
Phosphoproteomic analysis reveals interconnected system-wide responses to perturbations of kinases and phosphatases in yeast. Sci Signal (2010) 2.36
Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science (2004) 2.32
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood (2006) 2.32
Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. Science (2005) 2.32
Structural biology of shared cytokine receptors. Annu Rev Immunol (2009) 2.27
Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci U S A (2005) 2.27
Assessing computational methods for predicting protein stability upon mutation: good on average but not in the details. Protein Eng Des Sel (2009) 2.25
Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol (2003) 2.20
Antigen recognition determinants of gammadelta T cell receptors. Science (2005) 2.14
From single cells to deep phenotypes in cancer. Nat Biotechnol (2012) 2.12
Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor. Nat Struct Mol Biol (2005) 2.12
Structure of the measles virus hemagglutinin. Nat Struct Mol Biol (2007) 2.11
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proc Natl Acad Sci U S A (2010) 2.10
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature (2012) 2.08
High-affinity adaptors for switchable recognition of histidine-tagged proteins. J Am Chem Soc (2005) 2.06
Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron (2003) 2.06
Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. Immunity (2010) 2.05
Chemical labeling strategies for cell biology. Nat Methods (2006) 2.05
A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron (2005) 2.03
Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity (2005) 2.03
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology (2006) 2.03
An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication. J Virol (2004) 1.99
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells. Blood (2006) 1.93
Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry. J Immunol (2005) 1.93
The initial phase of an immune response functions to activate regulatory T cells. J Immunol (2009) 1.88
T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. Immunity (2011) 1.86
Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Mol Cell Biol (2006) 1.82
Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. Structure (2010) 1.79
Graded expression of semaphorin-1a cell-autonomously directs dendritic targeting of olfactory projection neurons. Cell (2007) 1.77
Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. Methods (2012) 1.75
Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J Immunol (2006) 1.72
Decoupling of tumor-initiating activity from stable immunophenotype in HoxA9-Meis1-driven AML. Cell Stem Cell (2012) 1.71
Specificity and degeneracy of T cells. Mol Immunol (2004) 1.71
A platinum-based covalent viability reagent for single-cell mass cytometry. Cytometry A (2012) 1.69
Polyspecificity of T cell and B cell receptor recognition. Semin Immunol (2007) 1.68
Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain. Science (2008) 1.67
Differential receptor subunit affinities of type I interferons govern differential signal activation. J Mol Biol (2006) 1.67
Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J Immunol (2005) 1.65
The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C. Liver Transpl (2009) 1.64
Deconstructing the form and function of the TCR/CD3 complex. Immunity (2006) 1.64
Structural snapshots of full-length Jak1, a transmembrane gp130/IL-6/IL-6Rα cytokine receptor complex, and the receptor-Jak1 holocomplex. Structure (2011) 1.63
The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol (2012) 1.63
The transcriptional landscape of αβ T cell differentiation. Nat Immunol (2013) 1.61
Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol (2009) 1.60
Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB. Chem Biol (2010) 1.60
USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response. PLoS One (2011) 1.60
The molecular architecture of protein-protein binding sites. Curr Opin Struct Biol (2007) 1.59
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis (2010) 1.58
Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance. Cancer Res (2008) 1.58
BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies. Protein Expr Purif (2008) 1.53
Specific and stable fluorescence labeling of histidine-tagged proteins for dissecting multi-protein complex formation. J Am Chem Soc (2006) 1.53